Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine infusion without loading dose for prevention of postoperative delirium in geriatric major non-cardiac surgery
PACTR202409743771278Phase 3Recruiting
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Incidence of delirium. Started Oct 2024; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on PACTR202409743771278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202409743771278.